AI compiles the protocol into structured, executable trial logic. Source-linked, human-approved, audit-ready. No black box.
AI reads the protocol PDF and compiles it into a governed, machine-readable model, builds the study from it, and monitors every connected system against it. Follow one protocol through the flow.
Hundreds of pages of rules, schedules, and criteria. Today teams read them and re-key them by hand into every system that runs the trial.
The document is scanned and every rule is extracted, typed, and validated. Each one stays linked to the exact clause it came from.
The compiled model is live context for Accura OS. An amendment is a recompile, reviewed by your team rather than re-typed across systems.
Accura OS holds a live link to each system in the trial. Signals flow in protocol context; issues arrive in red with evidence attached.
The AI does the busywork; your team keeps authority. These are the surfaces for building the study, absorbing amendments, watching data, and clearing queries.
Figures from our first live deployment. Source-linked outputs are reviewed by a human at key decision points.
The AI does the heavy lifting. Your team keeps sign-off. Every rule it extracts and every change it makes can be traced to its source, checked, and undone.
Nothing it produces is taken on faith.
It works within limits your team sets.
Why the industry was right to keep AI out, and the architecture that makes showing your work the product. Two notes from the founders.
The FDA gave its scientists an AI. Seven weeks later it was citing studies that don't exist. Why the skeptics were right, and the evidence-gated process that answers them.
Raw model output fails every data-integrity principle clinical trials run on. The checks, the failures that shaped them, and five questions to ask any vendor.
Bring one protocol PDF. Leave with a governed, machine-readable study.